Skip to main content
Professional Technical IVT

congenital myasthenic syndrome

Hereditary neuromuscular disorder caused by genetic defects affecting neuromuscular junction structure or function from birth.

Full Definition

Congenital myasthenic syndromes (CMS) are a heterogeneous group of inherited disorders affecting the neuromuscular junction, caused by mutations in genes encoding proteins essential for neuromuscular transmission. Unlike autoimmune myasthenia gravis, CMS symptoms typically begin in infancy or early childhood and result from structural or functional defects rather than autoimmune attack. Clinical presentation varies widely depending on the specific genetic defect but commonly includes muscle weakness, fatigability, and respiratory difficulties. Diagnosis requires clinical suspicion, electrophysiological testing, genetic analysis, and sometimes specialized studies of neuromuscular junction morphology. Treatment approaches differ from autoimmune myasthenia and depend on the specific molecular defect identified.

Usage

Usage note: CMS abbreviation acceptable; distinguish clearly from autoimmune myasthenia gravis in documentation.

In Context

  • "Genetic testing identified a CHAT gene mutation causing congenital myasthenic syndrome." — Molecular diagnosis report
  • "The infant's congenital myasthenic syndrome required ventilatory support and specialized feeding protocols." — Pediatric case management

Also known as

CMS

Don't confuse with

myasthenia gravis congenital myopathy

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON